HEB is required for the specification of fetal IL-17-producing γδ T cells

Tracy S. H. In(Sunnybrook Health Science Centre), Ashton Trotman‐Grant(Sunnybrook Health Science Centre), Shawn P. Fahl(Fox Chase Cancer Center), Edward L.Y. Chen(Sunnybrook Health Science Centre), Payam Zarin(Sunnybrook Health Science Centre), Amanda J. Moore(Sunnybrook Health Science Centre), David L. Wiest(Fox Chase Cancer Center), Juan Carlos Zúñiga‐Pflücker(Sunnybrook Health Science Centre), Michele K. Anderson(Sunnybrook Health Science Centre)
Nature Communications
December 4, 2017
Cited by 66Open Access
Full Text

Abstract

Abstract IL-17-producing γδ T (γδT17) cells are critical components of the innate immune system. However, the gene networks that control their development are unclear. Here we show that HEB (HeLa E-box binding protein, encoded by Tcf12 ) is required for the generation of a newly defined subset of fetal-derived CD73 − γδT17 cells. HEB is required in immature CD24 + CD73 − γδ T cells for the expression of Sox4 , Sox13 , and Rorc , and these genes are repressed by acute expression of the HEB antagonist Id3. HEB-deficiency also affects mature CD73 + γδ T cells, which are defective in RORγt expression and IL-17 production. Additionally, the fetal TCRγ chain repertoire is altered, and peripheral Vγ4 γδ T cells are mostly restricted to the IFNγ-producing phenotype in HEB-deficient mice. Therefore, our work identifies HEB-dependent pathways for the development of CD73 + and CD73 − γδT17 cells, and provides mechanistic evidence for control of the γδT17 gene network by HEB.


Related Papers

No related papers found

Powered by citation graph analysis